Skip to main content

Table 2 Clinicopathological Characteristics of Urothelial Carcinoma in Graft Kidney

From: Urothelial carcinoma of the graft kidney with molecular analyses: a rare case report

Reference No

Age at Transplant

Gender/ KT Type

Immuno suppressant

Initial Presentation

Age at UC Diagnosis

UC Grade

UC Stage

Interval KT to UC (month)

Treatment

F/U (Months)

[14]

41

F/DDKT

Steroid, CsA, AZA, MMF

No symptom

53

High

T3NxMx

147

NUx

Alive (94)

[10]

49

F/DDKT

Steroid, FK, MMF

Fever, Flank Pain, Urinary symptoms

61

High

T3NxMx

144

NUx

Alive (24)

[10]

57

F/DDKT

Steroid, FK, MMF

No symptom

59

High

T3NxMx

14

NUx

Alive (12)

[11]

46

M/DDKT

Steroid, CsA, AZA

No symptom

52

Low

T2NxMX

72

Partial Nephrectomy

Alive (14)

[12]

58

M/DDKT

Steroid, FK, MMF

Gross Hematuria

67

High

T2N3M1

108

CRTx

Dead (1.9)

[13]

29

M/LDKT

Steroid, CSA, MMF

Gross Hematuria

40

Low

T2NxMx

132

NUx + CRTx

Alive (24)

[8]

23

M/DDKT

N/A

Asymptomatic Microscopic Hematuria

30

High

T3NxMx

84

NUx

N/A

[9]

57

M/LDKT

FK Sirolimus

No symptom,

69

High

T3NxMx

144

NUx

Alive (12)

current case

28

F/LDKT

Steroid, AZA

UTI

62

High

T1N1M1

408

NUx

Alive (44)

  1. Abbreviations: AZA Azathioprine, CRTx Chemoradiotherapy, CsA Cyclosporine A, DDKT Deceased-donor kidney transplantation, F Female, F/U Follow-up, FK Tacrolimus, KT Kidney transplantation, LDKT Living donor kidney transplantation, M Male, MMF Mycophenolate mofetil, N/A Not available, Nux Nephroureterectomy, UC Urothelial carcinoma, UTI Urinary tract infection